Related Experiment Video
Updated: Mar 8, 2026
06:18
Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
Published on: August 18, 2023
3.9K
Minicircle-Based Engineering of Chimeric Antigen Receptor (CAR) T Cells
Michael Hudecek1, Tea Gogishvili1, Razieh Monjezi1
1Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany.
Summary
Minicircle DNA enhances the Sleeping Beauty transposon system for safer, more efficient gene therapy. This virus-free method rapidly produces chimeric antigen receptor T cells for advanced cellular therapies.
Area of Science:
- Gene Therapy
- Molecular Biology
- Immunotherapy
Background:
- Plasmid DNA is crucial for vaccines and gene therapies but carries risks like uncontrolled gene expression.
- Minicircle (MC) DNA, lacking bacterial sequences, offers a safer alternative to plasmids.
- The Sleeping Beauty (SB) transposon system facilitates genomic integration for gene delivery.
Purpose of the Study:
- To review MC-based SB transposition for chimeric antigen receptor (CAR) T cell engineering.
- To discuss advancements in MC manufacturing for faster clinical implementation.
- To highlight the advantages of MCs in advanced cellular and gene therapy.
Main Methods:
- Developed a strategy for MC-based SB transposition of CAR transgenes.
- Utilized MC DNA for virus-free gene transfer via SB-mediated transposition.
- Focused on enhancing transposition rates and transgene integration.
Main Results:
- MC platform significantly enhances SB transposition and transgene integration.
- Achieved improved transposition rates compared to conventional plasmids.
- Enabled rapid manufacturing of therapeutic CAR T cell doses.
Conclusions:
- MC-based SB transposition offers a safe and efficient virus-free method for CAR T cell manufacturing.
- MCs provide stable transposition, high CAR transgene expression, and reproducible handling.
- This approach accelerates pre-clinical and clinical implementation of advanced cellular therapies.
